GLP 3 (Retatrutide) (30mg)

GLP 3 (Retatrutide) is identified in the source as retatrutide, a long-acting triple agonist targeting GLP-1, GIP, and glucagon receptors. The source describes laboratory research involving these receptor-signaling pathways.